Smith & Nephew plc
NYSE:SNNMedical - Devices
-$0.43 today
- Market cap
- $12.72B
- Beta
- 0.67
- P/E (TTM)
- 20.1
- EPS (TTM)
- $0.74
- Dividend yield
- 2.59%
Volume 1.22M
Average 1.10M
SNN Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Smith & Nephew plcNYSE: SNN
Other Current Liabilities · Q4 FY2025 · quarter ended Dec 2025
Other current liabilities falls 41.3% from a year ago
Other current liabilities stood at $74M at the end of Q4 FY2025, down 41.3% from a year earlier. Over 3 fiscal years it compounded at -45.5% a year.
Context
- Other current liabilities amounted to 0.7% of total assets at the end of Q4 FY2025, down 0.5 pp from a year earlier.
- Other current liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -41.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 85M USD
- Year-over-year change
- -32.5%
- 4-year CAGR
- -38.6%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 85M | -32.5% |
| FY2024 | 2024-12-31 | 126M | -51.7% |
| FY2023 | 2023-12-31 | 261M | -50.4% |
| FY2022 | 2022-12-31 | 526M | -11.9% |
| FY2021 | 2021-12-31 | 597M | — |
Other Current Liabilities vs competitors
How SNN compares with its peers on the latest reported figures
- SNN's Dec 2025 other current liabilities of $74M is the 6th highest of the 11 companies compared; the peer median is $82.14M.
- Its year-over-year change of -41.3% is the 7th highest of 9, against a peer median of -3.0%.
- Other current liabilities amounts to 0.7% of total assets for SNN, versus a peer median of 3.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.6B | -6.0% | +5.3% | 5.4% | |
| Jun 2026 | $1.13B | -26.5% | -8.8% | 4.9% | |
| Apr 2026 | $191.31M | +26.2% | +27.8% | 5.0% | |
| Mar 2026 | $186.59M | -0.1% | +12.9% | 8.1% | |
| Mar 2026 | $106.23M | +13.1% | — | 12.0% | |
| Dec 2025 | $74M | -41.3% | -45.5% | 0.7% | |
| Mar 2026 | $58.04M | +10.8% | +4.2% | 1.6% | |
| Jun 2026 | $23.28M | -86.7% | +40.9% | 0.4% | |
| Mar 2026 | $11.78M | -45.9% | +34.2% | 2.3% | |
| Mar 2026 | $407K | — | — | 0.5% | |
| Mar 2026 | $0 | — | +124.4% | 0.0% | |
| Peer median (excluding SNN) | $82.14M | -3.0% | +20.4% | 3.6% | |
Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.29B | 350M | 302M | 619M | 557M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 971M | 1.03B | 1.06B | 1.21B | 1.43B |
| Inventory | 1.84B | 2.21B | 2.4B | 2.39B | 2.12B |
| Other Current Assets | 240M | 198M | 182M | 81M | (99M) |
| Total Current Assets | 4.42B | 3.86B | 4.03B | 4.42B | 4.1B |
| Property, Plant & Equipment (Net) | 1.51B | 1.46B | 1.47B | 1.42B | 1.64B |
| Goodwill | 2.99B | 3.03B | 2.99B | 3.03B | 3.11B |
| Intangible Assets | 1.4B | 1.24B | 1.11B | 1.03B | 882M |
| Long-term Investments | 380M | 58M | 24M | 16M | 151M |
| Tax Assets | 201M | 177M | 274M | 334M | 347M |
| Other Non-current Assets | 15M | 153M | 87M | 103M | 228M |
| Total Non-current Assets | 6.5B | 6.11B | 5.96B | 5.93B | 6.35B |
| Total Assets | 10.92B | 9.97B | 9.99B | 10.35B | 10.46B |
| Account Payables | 1.04B | 1.03B | 1.02B | 1.08B | 1.16B |
| Short-term Debt | 435M | 111M | 710M | 2M | 83M |
| Tax Payables | 222M | 214M | 218M | 232M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 597M | 526M | 261M | 126M | 85M |
| Total Current Liabilities | 2.13B | 1.72B | 2.27B | 1.53B | 1.6B |
| Long-term Debt | 2.71B | 2.57B | 2.18B | 3.12B | 3.03B |
| Deferred Tax Liabilities | 144M | 36M | 9M | 31M | 40M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 229M | 244M | 171M | 269M | 356M |
| Total Non-current Liabilities | 3.22B | 2.99B | 2.5B | 3.56B | 3.57B |
| Total Liabilities | 5.35B | 4.71B | 4.77B | 5.09B | 5.17B |
| Common Stock | 177M | 175M | 175M | 175M | 175M |
| Retained Earnings | 5.23B | 5.03B | 4.91B | 5.02B | 5.32B |
| Accumulated OCI | (328M) | (439M) | (385M) | 0 | 20M |
| Other Stockholders Equity | 0 | 0 | 0 | (497M) | (329M) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.57B | 5.26B | 5.22B | 5.27B | 5.29B |
| Total Debt | 3.34B | 2.87B | 3.08B | 3.32B | 3.33B |
| Net Debt | 2.05B | 2.52B | 2.78B | 2.7B | 2.77B |
Smith & Nephew plc
NYSE:SNN
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.